The Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire
An assessment tool that facilitates the identification and quantification of severity of both static and fluctuating non-motor symptoms that occur in Parkinson's disease.
Permission is required for each single use of the MDS Clinical Outcome Assessments.
The Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire is an assessment tool that facilitates the identification and quantification of severity of both static and fluctuating non-motor symptoms (NMF) that occur in Parkinson's disease. An initial version of the scale was developed following the FDA guidance on PRO development and validation. The current version was further validated and found to have good clinimetric properties with acceptable item utility, floor/ceiling effects, internal consistency, test-retest stability, construct validity, concurrent validity and scaling (via item response theory analyses).
Authors: Galit Kleiner, MD, Hubert H Fernandez MD, Kelvin L Chou MD, Alfonso A Fasano MD PhD , Kevin R Duque MD, Diana Hengartner MD, Albie Law BA, CCRA, Adam Margolius MD, Yu-Yan Poon RN, Michel Sáenz-Farret MD, Philip Saleh MD MSc, Joaquin Vizcarra MD, Glenn T Stebbins PhD, Alberto J Espay MD MSc on behalf of the PSG NoMoFA Working Group
Original Publication │ View the Scale (PDF) │View the Score Sheet (PDF) Permission required for use
- Acronym: NoMoFA
- Year Published: 2021
- Scale Last Updated: February 5, 2021
- Estimated Time to Complete the Scale: 15-20minutes
- Assessment Type: Patient-Reported Outcome (PRO)
Available translations: 4 languages
Eletronic builds: REDCap
Available Translations
- German
- Italian
- Spanish
- Turkish
Inclusive Language in Clinical Outcome AssessmentsHealthcare providers should tailor the language used in COAs to reflect each patient’s gender identity. In grammatically gendered languages, the practice includes making appropriate linguistic adjustments to ensure communication is respectful and inclusive throughout the assessment process. |